Laboratory Corporation of America Holdings (NYSE:LH) does about 764.68K shares in volume on a normal day but saw 641049 shares change hands in Tuesday trading. The company now has a market cap of 21.23B USD. Its current market price is $236.75, marking an increase of 0.37% compared to the previous close of $235.88. The 52 week high reached by this stock is $317.17 whilst the lowest price level in 52 weeks is $200.32. The script in recent trading has seen the stock touch a high of $237.975 and a low of $235.00.
Laboratory Corporation of America Holdings (LH) has a 20-day trading average at $232.68 and the current price is -25.36% off the 52-week high compared with 18.19% distance from its 52-week low. The 50-day simple moving average of the closing price is $220.80 and its 200-day simple moving average is $244.53. If we look at the stock’s price movements over the week, volatility stands at 3.43%, which decreases to 3.31% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 55.71 to suggest the stock is neutral.
17 analysts observing the Laboratory Corporation of America Holdings (LH) stock have set the 12-month price targets for the company’s shares at between $250.00 and $315.00. The consensus objective for the share price is $278.69, suggesting that the stock has a potential upside of 15.05% over the period. The median price target is 13.91% away from the current levels at $275.00.
FactSet Research has provided data showing that 17 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 2 advise that it is a overweight. 12 analysts have rated it as a buy and 3 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
Deutsche Bank downgraded its price target at $330-$294.
The current price level is 1.94%, 7.31%, and -3.26% away from its SMA20, SMA50, and SMA200 respectively, with the LH price moving above the 50-day SMA on November 22. Laboratory Corporation of America Holdings (LH) stock is down -3.67% over the week and 10.27% over the past month. Its price is -24.65% year-to-date and -16.57% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of $4.68 above consensus estimates by $0.01. The company’s next earnings report is expected on 02/09/2023, with forecasts estimating quarterly EPS at $4.52 and $20.19 for whole year. LH’s earnings per share are forecast to shrink by -29.20% this year and -11.20% over next year. Expected sales for next quarter are $3.71 billion, which analysts say will come at $15.16 billion for the current fiscal year and next year at $15.2 billion. In addition, estimates put the company’s current quarterly revenue at an average of $3.8 billion.
Its 12-month price target is $275.00. To reach the target analysts have set, the stock logically needs to grow 15.05 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $250.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $315.00.
Outstanding shares total 90.20M with insiders holding 0.26% of the shares and institutional holders owning 94.98% of the company’s common stock. The company has a return on investment of 15.90% and return on equity of 16.90%. The price to earnings ratio (P/E ratio) amounts to 12.64 while the forward price to earnings ratio is 13.43. The beta has a value of 1.07. Price to book ratio is 2.12 and price to sales ratio is 1.39.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has added its position in Laboratory Corporation of America Holdings (LH) to 2,711,961 shares, mirroring a recent increase by 0.56%. Vanguard Total Stock Market Index added 15109.0 shares of Laboratory Corporation of America Holdings common stock bringing its total worth to about $601.68 million at the end of recent close, SEC documents show. Vanguard Total Stock Market Index isn’t the only investment manager who changed stakes and is followed by Vanguard Mid Cap Index Fund, which added 26665.0 shares to end up with 2,111,761 shares worth $468.52 million. Vanguard 500 Index Fund raise their holdings by 0.98% in the company over the course of the most recent quarter. It now holds a 2.29% position in Laboratory Corporation of America Holdings thanks to 2.07 million shares amounting to $458.93 million.